Frederic Moll - 06 Dec 2023 Form 4 Insider Report for PROCEPT BioRobotics Corp (PRCT)

Role: Director
Signature: /s/ Jonathan Stone, Attorney-in-Fact for Frederic Moll
Issuer symbol: PRCT
Transactions as of: 06 Dec 2023
Transactions value $: -$3,061,355
Form type: 4
Filing time: 08 Dec 2023, 17:33:03
Previous filing: 16 Jun 2023
Next filing: 09 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PRCT	Common Stock	Sale	-$1.99M	-51.8K	-5.83%	$38.49	835K	06 Dec 2023	Direct	F1
transaction	PRCT	Common Stock	Sale	-$1.07M	-27.2K	-3.26%	$39.25	808K	06 Dec 2023	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.1800 to $39.1799, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.180 to $40.1799, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.1800 to $39.1799, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.180 to $40.1799, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.